The Dynamic Media, Sera and Reagent Market in Biotechnology
September 16, 2010
Wellesley, Mass. – According to a new technical market research report, THE DYNAMIC MEDIA, SERA AND REAGENT MARKET IN BIOTECHNOLOGY (BIO014F) from BCC Research (www.bccresearch.com), the global market value of dynamic media, sera and reagent products is an estimated $2.5 billion in 2010, but is expected to increase to nearly $3.9 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 8.7%.
The largest segment of the market, made up of reagents, is projected to grow at a CAGR of 11.6% to reach nearly $1.9 billion in 2015. Its value is estimated at nearly $1.1 billion in 2010.
The media segment is estimated at $822 million in 2010, and is expected to increase at a 5-year CAGR of 8.6% to reach more than $1.2 billion in 2015.
The sera segment is projected to have a 5-year CAGR of 13.3%, rising from $658 million in 2010 to nearly $773 million in 2015.
Cell culture, a crucial component of the life-sciences industry, has witnessed major developments in the past three decades. Cell culture techniques have developed substantially and are now an integral part of biotechnology. During the evolution of cell culture technologies, a number of disciplines, such as cell biology, genetic engineering, protein chemistry, genomics, and chemical engineering, have been successfully incorporated into the cell culture field. Cell cultures have extensive applications in toxicology studies for initial-stage screening of compounds in drug discovery. Cell/tissue culture involves assorted range of media, sera, and reagents.
Increasing demand for influenza vaccines has forced manufacturers to put great effort into the production of vaccines through cell culture procedures. This technique could provide an alternative approach for the manufacture of vaccines. Increased research efforts to make cell culture-based vaccines have increased the growth of the cell culture market. Cell culture-based vaccines will be the growth driver for the cell culture market in the future also.
This study contributes to the areas of market growth in the cell culture industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.

Source: BCC Research
The Dynamic Media, Sera and Reagent Market in Biotechnology( BIO014F )
Publish Date: Jul 2010
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum